HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC ROA

The Return on Assets (ROA) of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 2, 2026 is 3.73 %. In the previous year, Return on Assets (ROA) was 4.63 % — a change of -19.47% (lower).

ROA

3.73 %

YoY

-19.47%

Last updated:

In 2024, HaTay Pharmaceutical JSC's return on assets (ROA) was 3.73 %, a -19.47% increase from the 4.63 % ROA in the previous year.

The HaTay Pharmaceutical JSC ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2017
11.37 VND
Jan 1, 2018
12.69 VND
Jan 1, 2019
11.68 VND
Jan 1, 2020
10.00 VND
Jan 1, 2021
5.49 VND
Jan 1, 2022
6.48 VND
Jan 1, 2023
4.63 VND
Jan 1, 2024
3.73 VND
The HaTay Pharmaceutical JSC ROA history
YEARROAYoY
3.73 %-19.47%
4.63 %-28.59%
6.48 %+18.01%
5.49 %-45.12%
10.00 %-14.35%
11.68 %-7.92%
12.69 %+11.62%
11.37 %+16.75%
9.73 %+23.70%
7.87 %+7.74%
7.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

ROA Details

Understanding HaTay Pharmaceutical JSC's Return on Assets (ROA)

HaTay Pharmaceutical JSC's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing HaTay Pharmaceutical JSC's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider HaTay Pharmaceutical JSC's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in HaTay Pharmaceutical JSC’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Return on Assets (ROA) of HaTay Pharmaceutical JSC is 3.73 % in 2024.

Return on Assets (ROA) of HaTay Pharmaceutical JSC changed from 4.63 % to 3.73 %, representing a -19.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s HaTay Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — HaTay Pharmaceutical JSC

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — HaTay Pharmaceutical JSC